INSM1 Expression in Mesenchymal Tumors and Its Clinicopathological Significance

Table 2

INSM1 expression of hematologic neoplasms mentioned in this study.

Neoplasms histologic type	Number of positive cases/total cases (%)
Plasmablastic lymphoma	2/4 (50%)
Angioimmunoblastic T-cell lymphoma	18/38 (47.4%)
Burkitt’s lymphoma	7/21 (33.3%)
Follicular lymphoma	9/28 (32.1%)
Marginal zone lymphoma	15/51 (29.4%)
Diffuse large B-cell lymphoma	5/19 (28.3%)
Mantle cell lymphoma	8/46 (17.4%)
T/B lymphoblastic lymphoma	4/33 (12.1%)
Hodgkin’s lymphoma	1/14 (7.1%)
Small lymphocytic lymphoma	0/17 (0%)
NK/T-cell lymphoma	0/7 (0%)
Anaplastic large cell lymphoma	0/11 (0%)